Literature DB >> 12586007

[Endoscopic dilatation of caustic esophageal strictures].

P López Vallejos1, M V García Sánchez, A Naranjo Rodríguez, C Gálvez Calderón, A Hervás Molina, M Chicano Gallardo, G Miño Fugarolas.   

Abstract

OBJECTIVE: To evaluate the results of endoscopic dilatation in caustic esophageal strictures and to analyze the factors associated with a favorable response. PATIENTS AND
METHOD: We performed a retrospective study of 33 patients who underwent dilatation with Savary bougie between 1989 and 2001. Response to initial dilatation and outcome during follow-up were analyzed.
RESULTS: The mean age was 50 years (8-83) and 58% were women. Intake was accidental in 29 (88%). In all patients, the caustic substance ingested was alkali. Dilatation was started in the acute phase in 12 patients (36%) and 13 presented inflammatory phenomena adjacent to the stenosis. During initial dilatation, 2 1.6 sessions (2-18) were performed and a favorable response was obtained in 18 patients (54%). At the end of follow-up, 68% of the patients presented satisfactory health status. The comparative study revealed that statistically significant variables for a favorable response to treatment were: accidental alkali intake, instauration of treatment in the chronic phase, absence of inflammatory phenomena, and a small number of initial dilatation sessions.
CONCLUSIONS: In our series, more than half the patients with esophageal stenosis due to intake of corrosive alkalis showed a favorable initial response. In these patients with acute-phase stenosis who required a greater number of initial dilatation sessions, endoscopic therapy was less effective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586007     DOI: 10.1016/s0210-5705(03)79062-1

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  1 in total

1.  Surgical management of esophageal strictures after caustic burns: a 30 years of experience.

Authors:  Yong Han; Qing-Shu Cheng; Xiao-Fei Li; Xiao-Ping Wang
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.